InvestorsHub Logo
icon url

BioChica

02/22/14 7:00 AM

#25496 RE: johnking29 #25493

I still feel the government needs to scrap the system. Once any drug has gone through the FDA process, they should be given 5 years of protection regardless! Dug development is very expensive, why should the generic companies get a free ride? After that let the patent system do it's job!
icon url

CHARLIE125

02/22/14 8:22 AM

#25498 RE: johnking29 #25493

... FDA has awarded three years of marketing exclusivity to Vascepa® (icosapent ethyl) capsules in connection with the July 26, 2012 approval of Vascepa pursuant to the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. Such exclusivity extends through July 25, 2015 and is expected to be supplemented by a 30-month stay under the Hatch-Waxman Amendments that would be triggered after patent infringement litigation initiated by Amarin following valid notice to Amarin of the acceptance of an application to the FDA seeking approval of a generic version of Vascepa."
entonces tambien estan apelando o reclamando esto? eso creo entender. AMRN

http://files.shareholder.com/downloads/AMRN/2938370790x0x727779/a5c01486-7edc-45db-b0f5-cd7fada6d933/AMRN_News_2014_2_21_General_Releases.pdf


Monday we see it